Global Molecular Biology Enzymes and Kits & Reagents Market to Reach $26 Billion by 2027

Abstract: - Global Molecular Biology Enzymes and Kits & Reagents Market to Reach $26 Billion by 2027. - Amid the COVID-19 crisis, the global market for Molecular Biology Enzymes and Kits & Reagents estimated at US$13.

New York, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Molecular Biology Enzymes and Kits & Reagents Industry" - https://www.reportlinker.com/p06032263/?utm_source=GNW
7 Billion in the year 2020, is projected to reach a revised size of US$26 Billion by 2027, growing at aCAGR of 9.6% over the period 2020-2027. Kits & Reagents, one of the segments analyzed in the report, is projected to record 10.1% CAGR and reach US$19 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Enzymes segment is readjusted to a revised 8.4% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $4.1 Billion, While China is Forecast to Grow at 9% CAGR
- The Molecular Biology Enzymes and Kits & Reagents market in the U.S. is estimated at US$4.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.5 Billion by the year 2027 trailing a CAGR of 9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.9% and 7.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.7% CAGR.

- Select Competitors (Total 33 Featured) -

• Affymetrix, Inc.

• Agilent Technologies, Inc.

• Bio-Rad Laboratories, Inc.

• Enzymatics

• F. Hoffmann-La Roche Ltd.

• Illumina, Inc.

• LGC Limited

• Merck KGaA

• New England Biolabs

• Promega Corporation

• QIAGEN

• Sigma-Aldrich Co. LLC

• Takara Bio, Inc.

• Thermo Fisher Scientific, Inc.

Read the full report: https://www.reportlinker.com/p06032263/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Molecular Biology
Enzymes and Kits & Reagents by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 2: World Historic Review for Molecular Biology Enzymes
and Kits & Reagents by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Molecular Biology
Enzymes and Kits & Reagents by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets for Years 2012, 2020 &
2027

Table 4: World Current & Future Analysis for Kits & Reagents by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 5: World Historic Review for Kits & Reagents by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 6: World 15-Year Perspective for Kits & Reagents by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Enzymes by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 8: World Historic Review for Enzymes by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Enzymes by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 10: World Current & Future Analysis for Academic &
Research by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 11: World Historic Review for Academic & Research by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Academic & Research by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Hospital &
Diagnostics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 14: World Historic Review for Hospital & Diagnostics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 15: World 15-Year Perspective for Hospital & Diagnostics
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 17: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 18: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Pharma & Biotech
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 20: World Historic Review for Pharma & Biotech by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 21: World 15-Year Perspective for Pharma & Biotech by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Sequencing by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 23: World Historic Review for Sequencing by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Sequencing by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for PCR by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2020 through 2027 and % CAGR

Table 26: World Historic Review for PCR by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for PCR by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 28: World Current & Future Analysis for Cloning by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 29: World Historic Review for Cloning by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 30: World 15-Year Perspective for Cloning by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 31: World Current & Future Analysis for Epigenetics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 32: World Historic Review for Epigenetics by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 33: World 15-Year Perspective for Epigenetics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 34: World Current & Future Analysis for Restriction
Digestion by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 35: World Historic Review for Restriction Digestion by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 36: World 15-Year Perspective for Restriction Digestion
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 37: World Current & Future Analysis for Other
Applications by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 38: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 39: World 15-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 40: USA Current & Future Analysis for Molecular Biology
Enzymes and Kits & Reagents by Product - Kits & Reagents and
Enzymes - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 41: USA Historic Review for Molecular Biology Enzymes and
Kits & Reagents by Product - Kits & Reagents and Enzymes
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 42: USA 15-Year Perspective for Molecular Biology Enzymes
and Kits & Reagents by Product - Percentage Breakdown of Value
Sales for Kits & Reagents and Enzymes for the Years 2012, 2020 &
2027

Table 43: USA Current & Future Analysis for Molecular Biology
Enzymes and Kits & Reagents by End-Use - Academic & Research,
Hospital & Diagnostics, Other End-Uses and Pharma & Biotech -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 44: USA Historic Review for Molecular Biology Enzymes and
Kits & Reagents by End-Use - Academic & Research, Hospital &
Diagnostics, Other End-Uses and Pharma & Biotech Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 45: USA 15-Year Perspective for Molecular Biology Enzymes
and Kits & Reagents by End-Use - Percentage Breakdown of Value
Sales for Academic & Research, Hospital & Diagnostics, Other
End-Uses and Pharma & Biotech for the Years 2012, 2020 & 2027

Table 46: USA Current & Future Analysis for Molecular Biology
Enzymes and Kits & Reagents by Application - Sequencing, PCR,
Cloning, Epigenetics, Restriction Digestion and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 47: USA Historic Review for Molecular Biology Enzymes and
Kits & Reagents by Application - Sequencing, PCR, Cloning,
Epigenetics, Restriction Digestion and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 48: USA 15-Year Perspective for Molecular Biology Enzymes
and Kits & Reagents by Application - Percentage Breakdown of
Value Sales for Sequencing, PCR, Cloning, Epigenetics,
Restriction Digestion and Other Applications for the Years
2012, 2020 & 2027

CANADA
Table 49: Canada Current & Future Analysis for Molecular
Biology Enzymes and Kits & Reagents by Product - Kits &
Reagents and Enzymes - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 50: Canada Historic Review for Molecular Biology Enzymes
and Kits & Reagents by Product - Kits & Reagents and Enzymes
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 51: Canada 15-Year Perspective for Molecular Biology
Enzymes and Kits & Reagents by Product - Percentage Breakdown
of Value Sales for Kits & Reagents and Enzymes for the Years
2012, 2020 & 2027

Table 52: Canada Current & Future Analysis for Molecular
Biology Enzymes and Kits & Reagents by End-Use - Academic &
Research, Hospital & Diagnostics, Other End-Uses and Pharma &
Biotech - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 53: Canada Historic Review for Molecular Biology Enzymes
and Kits & Reagents by End-Use - Academic & Research, Hospital &
Diagnostics, Other End-Uses and Pharma & Biotech Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 54: Canada 15-Year Perspective for Molecular Biology
Enzymes and Kits & Reagents by End-Use - Percentage Breakdown
of Value Sales for Academic & Research, Hospital & Diagnostics,
Other End-Uses and Pharma & Biotech for the Years 2012, 2020 &
2027

Table 55: Canada Current & Future Analysis for Molecular
Biology Enzymes and Kits & Reagents by Application -
Sequencing, PCR, Cloning, Epigenetics, Restriction Digestion
and Other Applications - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 56: Canada Historic Review for Molecular Biology Enzymes
and Kits & Reagents by Application - Sequencing, PCR, Cloning,
Epigenetics, Restriction Digestion and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 57: Canada 15-Year Perspective for Molecular Biology
Enzymes and Kits & Reagents by Application - Percentage
Breakdown of Value Sales for Sequencing, PCR, Cloning,
Epigenetics, Restriction Digestion and Other Applications for
the Years 2012, 2020 & 2027

JAPAN
Table 58: Japan Current & Future Analysis for Molecular Biology
Enzymes and Kits & Reagents by Product - Kits & Reagents and
Enzymes - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 59: Japan Historic Review for Molecular Biology Enzymes
and Kits & Reagents by Product - Kits & Reagents and Enzymes
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 60: Japan 15-Year Perspective for Molecular Biology
Enzymes and Kits & Reagents by Product - Percentage Breakdown
of Value Sales for Kits & Reagents and Enzymes for the Years
2012, 2020 & 2027

Table 61: Japan Current & Future Analysis for Molecular Biology
Enzymes and Kits & Reagents by End-Use - Academic & Research,
Hospital & Diagnostics, Other End-Uses and Pharma & Biotech -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 62: Japan Historic Review for Molecular Biology Enzymes
and Kits & Reagents by End-Use - Academic & Research, Hospital &
Diagnostics, Other End-Uses and Pharma & Biotech Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 63: Japan 15-Year Perspective for Molecular Biology
Enzymes and Kits & Reagents by End-Use - Percentage Breakdown
of Value Sales for Academic & Research, Hospital & Diagnostics,
Other End-Uses and Pharma & Biotech for the Years 2012, 2020 &
2027

Table 64: Japan Current & Future Analysis for Molecular Biology
Enzymes and Kits & Reagents by Application - Sequencing, PCR,
Cloning, Epigenetics, Restriction Digestion and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 65: Japan Historic Review for Molecular Biology Enzymes
and Kits & Reagents by Application - Sequencing, PCR, Cloning,
Epigenetics, Restriction Digestion and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 66: Japan 15-Year Perspective for Molecular Biology
Enzymes and Kits & Reagents by Application - Percentage
Breakdown of Value Sales for Sequencing, PCR, Cloning,
Epigenetics, Restriction Digestion and Other Applications for
the Years 2012, 2020 & 2027

CHINA
Table 67: China Current & Future Analysis for Molecular Biology
Enzymes and Kits & Reagents by Product - Kits & Reagents and
Enzymes - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 68: China Historic Review for Molecular Biology Enzymes
and Kits & Reagents by Product - Kits & Reagents and Enzymes
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 69: China 15-Year Perspective for Molecular Biology
Enzymes and Kits & Reagents by Product - Percentage Breakdown
of Value Sales for Kits & Reagents and Enzymes for the Years
2012, 2020 & 2027

Table 70: China Current & Future Analysis for Molecular Biology
Enzymes and Kits & Reagents by End-Use - Academic & Research,
Hospital & Diagnostics, Other End-Uses and Pharma & Biotech -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 71: China Historic Review for Molecular Biology Enzymes
and Kits & Reagents by End-Use - Academic & Research, Hospital &
Diagnostics, Other End-Uses and Pharma & Biotech Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 72: China 15-Year Perspective for Molecular Biology
Enzymes and Kits & Reagents by End-Use - Percentage Breakdown
of Value Sales for Academic & Research, Hospital & Diagnostics,
Other End-Uses and Pharma & Biotech for the Years 2012, 2020 &
2027

Table 73: China Current & Future Analysis for Molecular Biology
Enzymes and Kits & Reagents by Application - Sequencing, PCR,
Cloning, Epigenetics, Restriction Digestion and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 74: China Historic Review for Molecular Biology Enzymes
and Kits & Reagents by Application - Sequencing, PCR, Cloning,
Epigenetics, Restriction Digestion and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 75: China 15-Year Perspective for Molecular Biology
Enzymes and Kits & Reagents by Application - Percentage
Breakdown of Value Sales for Sequencing, PCR, Cloning,
Epigenetics, Restriction Digestion and Other Applications for
the Years 2012, 2020 & 2027

EUROPE
Table 76: Europe Current & Future Analysis for Molecular
Biology Enzymes and Kits & Reagents by Geographic Region -
France, Germany, Italy, UK and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 77: Europe Historic Review for Molecular Biology Enzymes
and Kits & Reagents by Geographic Region - France, Germany,
Italy, UK and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 78: Europe 15-Year Perspective for Molecular Biology
Enzymes and Kits & Reagents by Geographic Region - Percentage
Breakdown of Value Sales for France, Germany, Italy, UK and
Rest of Europe Markets for Years 2012, 2020 & 2027

Table 79: Europe Current & Future Analysis for Molecular
Biology Enzymes and Kits & Reagents by Product - Kits &
Reagents and Enzymes - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 80: Europe Historic Review for Molecular Biology Enzymes
and Kits & Reagents by Product - Kits & Reagents and Enzymes
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 81: Europe 15-Year Perspective for Molecular Biology
Enzymes and Kits & Reagents by Product - Percentage Breakdown
of Value Sales for Kits & Reagents and Enzymes for the Years
2012, 2020 & 2027

Table 82: Europe Current & Future Analysis for Molecular
Biology Enzymes and Kits & Reagents by End-Use - Academic &
Research, Hospital & Diagnostics, Other End-Uses and Pharma &
Biotech - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 83: Europe Historic Review for Molecular Biology Enzymes
and Kits & Reagents by End-Use - Academic & Research, Hospital &
Diagnostics, Other End-Uses and Pharma & Biotech Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 84: Europe 15-Year Perspective for Molecular Biology
Enzymes and Kits & Reagents by End-Use - Percentage Breakdown
of Value Sales for Academic & Research, Hospital & Diagnostics,
Other End-Uses and Pharma & Biotech for the Years 2012, 2020 &
2027

Table 85: Europe Current & Future Analysis for Molecular
Biology Enzymes and Kits & Reagents by Application -
Sequencing, PCR, Cloning, Epigenetics, Restriction Digestion
and Other Applications - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 86: Europe Historic Review for Molecular Biology Enzymes
and Kits & Reagents by Application - Sequencing, PCR, Cloning,
Epigenetics, Restriction Digestion and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 87: Europe 15-Year Perspective for Molecular Biology
Enzymes and Kits & Reagents by Application - Percentage
Breakdown of Value Sales for Sequencing, PCR, Cloning,
Epigenetics, Restriction Digestion and Other Applications for
the Years 2012, 2020 & 2027

FRANCE
Table 88: France Current & Future Analysis for Molecular
Biology Enzymes and Kits & Reagents by Product - Kits &
Reagents and Enzymes - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 89: France Historic Review for Molecular Biology Enzymes
and Kits & Reagents by Product - Kits & Reagents and Enzymes
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 90: France 15-Year Perspective for Molecular Biology
Enzymes and Kits & Reagents by Product - Percentage Breakdown
of Value Sales for Kits & Reagents and Enzymes for the Years
2012, 2020 & 2027

Table 91: France Current & Future Analysis for Molecular
Biology Enzymes and Kits & Reagents by End-Use - Academic &
Research, Hospital & Diagnostics, Other End-Uses and Pharma &
Biotech - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 92: France Historic Review for Molecular Biology Enzymes
and Kits & Reagents by End-Use - Academic & Research, Hospital &
Diagnostics, Other End-Uses and Pharma & Biotech Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 93: France 15-Year Perspective for Molecular Biology
Enzymes and Kits & Reagents by End-Use - Percentage Breakdown
of Value Sales for Academic & Research, Hospital & Diagnostics,
Other End-Uses and Pharma & Biotech for the Years 2012, 2020 &
2027

Table 94: France Current & Future Analysis for Molecular
Biology Enzymes and Kits & Reagents by Application -
Sequencing, PCR, Cloning, Epigenetics, Restriction Digestion
and Other Applications - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 95: France Historic Review for Molecular Biology Enzymes
and Kits & Reagents by Application - Sequencing, PCR, Cloning,
Epigenetics, Restriction Digestion and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 96: France 15-Year Perspective for Molecular Biology
Enzymes and Kits & Reagents by Application - Percentage
Breakdown of Value Sales for Sequencing, PCR, Cloning,
Epigenetics, Restriction Digestion and Other Applications for
the Years 2012, 2020 & 2027

GERMANY
Table 97: Germany Current & Future Analysis for Molecular
Biology Enzymes and Kits & Reagents by Product - Kits &
Reagents and Enzymes - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 98: Germany Historic Review for Molecular Biology Enzymes
and Kits & Reagents by Product - Kits & Reagents and Enzymes
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 99: Germany 15-Year Perspective for Molecular Biology
Enzymes and Kits & Reagents by Product - Percentage Breakdown
of Value Sales for Kits & Reagents and Enzymes for the Years
2012, 2020 & 2027

Table 100: Germany Current & Future Analysis for Molecular
Biology Enzymes and Kits & Reagents by End-Use - Academic &
Research, Hospital & Diagnostics, Other End-Uses and Pharma &
Biotech - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 101: Germany Historic Review for Molecular Biology
Enzymes and Kits & Reagents by End-Use - Academic & Research,
Hospital & Diagnostics, Other End-Uses and Pharma & Biotech
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 102: Germany 15-Year Perspective for Molecular Biology
Enzymes and Kits & Reagents by End-Use - Percentage Breakdown
of Value Sales for Academic & Research, Hospital & Diagnostics,
Other End-Uses and Pharma & Biotech for the Years 2012, 2020 &
2027

Table 103: Germany Current & Future Analysis for Molecular
Biology Enzymes and Kits & Reagents by Application -
Sequencing, PCR, Cloning, Epigenetics, Restriction Digestion
and Other Applications - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 104: Germany Historic Review for Molecular Biology
Enzymes and Kits & Reagents by Application - Sequencing, PCR,
Cloning, Epigenetics, Restriction Digestion and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 105: Germany 15-Year Perspective for Molecular Biology
Enzymes and Kits & Reagents by Application - Percentage
Breakdown of Value Sales for Sequencing, PCR, Cloning,
Epigenetics, Restriction Digestion and Other Applications for
the Years 2012, 2020 & 2027

ITALY
Table 106: Italy Current & Future Analysis for Molecular
Biology Enzymes and Kits & Reagents by Product - Kits &
Reagents and Enzymes - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 107: Italy Historic Review for Molecular Biology Enzymes
and Kits & Reagents by Product - Kits & Reagents and Enzymes
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 108: Italy 15-Year Perspective for Molecular Biology
Enzymes and Kits & Reagents by Product - Percentage Breakdown
of Value Sales for Kits & Reagents and Enzymes for the Years
2012, 2020 & 2027

Table 109: Italy Current & Future Analysis for Molecular
Biology Enzymes and Kits & Reagents by End-Use - Academic &
Research, Hospital & Diagnostics, Other End-Uses and Pharma &
Biotech - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 110: Italy Historic Review for Molecular Biology Enzymes
and Kits & Reagents by End-Use - Academic & Research, Hospital &
Diagnostics, Other End-Uses and Pharma & Biotech Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 111: Italy 15-Year Perspective for Molecular Biology
Enzymes and Kits & Reagents by End-Use - Percentage Breakdown
of Value Sales for Academic & Research, Hospital & Diagnostics,
Other End-Uses and Pharma & Biotech for the Years 2012, 2020 &
2027

Table 112: Italy Current & Future Analysis for Molecular
Biology Enzymes and Kits & Reagents by Application -
Sequencing, PCR, Cloning, Epigenetics, Restriction Digestion
and Other Applications - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 113: Italy Historic Review for Molecular Biology Enzymes
and Kits & Reagents by Application - Sequencing, PCR, Cloning,
Epigenetics, Restriction Digestion and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 114: Italy 15-Year Perspective for Molecular Biology
Enzymes and Kits & Reagents by Application - Percentage
Breakdown of Value Sales for Sequencing, PCR, Cloning,
Epigenetics, Restriction Digestion and Other Applications for
the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 115: UK Current & Future Analysis for Molecular Biology
Enzymes and Kits & Reagents by Product - Kits & Reagents and
Enzymes - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 116: UK Historic Review for Molecular Biology Enzymes and
Kits & Reagents by Product - Kits & Reagents and Enzymes
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 117: UK 15-Year Perspective for Molecular Biology Enzymes
and Kits & Reagents by Product - Percentage Breakdown of Value
Sales for Kits & Reagents and Enzymes for the Years 2012, 2020 &
2027

Table 118: UK Current & Future Analysis for Molecular Biology
Enzymes and Kits & Reagents by End-Use - Academic & Research,
Hospital & Diagnostics, Other End-Uses and Pharma & Biotech -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 119: UK Historic Review for Molecular Biology Enzymes and
Kits & Reagents by End-Use - Academic & Research, Hospital &
Diagnostics, Other End-Uses and Pharma & Biotech Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 120: UK 15-Year Perspective for Molecular Biology Enzymes
and Kits & Reagents by End-Use - Percentage Breakdown of Value
Sales for Academic & Research, Hospital & Diagnostics, Other
End-Uses and Pharma & Biotech for the Years 2012, 2020 & 2027

Table 121: UK Current & Future Analysis for Molecular Biology
Enzymes and Kits & Reagents by Application - Sequencing, PCR,
Cloning, Epigenetics, Restriction Digestion and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 122: UK Historic Review for Molecular Biology Enzymes and
Kits & Reagents by Application - Sequencing, PCR, Cloning,
Epigenetics, Restriction Digestion and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 123: UK 15-Year Perspective for Molecular Biology Enzymes
and Kits & Reagents by Application - Percentage Breakdown of
Value Sales for Sequencing, PCR, Cloning, Epigenetics,
Restriction Digestion and Other Applications for the Years
2012, 2020 & 2027

REST OF EUROPE
Table 124: Rest of Europe Current & Future Analysis for
Molecular Biology Enzymes and Kits & Reagents by Product - Kits &
Reagents and Enzymes - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 125: Rest of Europe Historic Review for Molecular Biology
Enzymes and Kits & Reagents by Product - Kits & Reagents and
Enzymes Markets - Independent Analysis of Annual Sales in US$

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06032263/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001